Loading people...
Chris Picariello is the President of Johnson & Johnson Innovation JJDC, based in Cambridge, Massachusetts. In this role, he oversees a global corporate venture capital fund that deployed $3.5 billion between 2014 and 2023, executing 50 investments and exits in 2022 alone while managing a portfolio of over 170 active healthcare startups. Prior to leading JJDC and the JLABS incubator network, he held multiple executive positions during his decades-long tenure at Johnson & Johnson, including Chief Financial Officer of Janssen Research & Development and CFO of the North American consumer division. He earned a Bachelor of Science in Accounting from LaSalle University in 1995 before advancing through various corporate finance and project management roles. Picariello currently focuses on directing strategic venture capital investments and company creation initiatives across the biotechnology, pharmaceutical, and medical device sectors.
As President of Johnson & Johnson Innovation, Chris Picariello plays a pivotal role in shaping the future of global healthcare. In this capacity, he leads the organization's efforts to discover, develop, and commercialize transformative healthcare solutions through strategic investments, collaborations, and partnerships. Johnson & Johnson Innovation, under Picariello's guidance, is dedicated to working with entrepreneurs, startups, and academic institutions worldwide to accelerate the development of disruptive technologies and scientific breakthroughs.
Picariello's investment focus areas are broad yet strategically aligned with Johnson & Johnson's core businesses. These include pharmaceuticals, medical devices, and consumer health. Within these sectors, he and his team actively seek out promising innovations in areas such as biotechnology, digital health, artificial intelligence, surgical technologies, advanced materials, and personalized medicine. The goal is to identify early-stage companies and innovative platforms that have the potential to significantly impact patient care and improve health outcomes globally. Through a network of innovation centers located in key biotech hubs, Johnson & Johnson Innovation provides not only capital but also scientific expertise, mentorship, and access to Johnson & Johnson's vast resources.
Chris Picariello's career background reflects a deep understanding of the healthcare industry and a strong track record in strategic leadership and business development. His experience has equipped him with the insights necessary to navigate the complex landscape of healthcare innovation, identify high-potential opportunities, and forge successful partnerships. He is known for fostering an environment that encourages scientific discovery and entrepreneurial spirit, ensuring that Johnson & Johnson remains at the forefront of medical advancement.
While specific individual investments are typically managed by the broader Johnson & Johnson Innovation team, Picariello's leadership oversees a robust portfolio of strategic alliances and equity investments. These collaborations are designed to bring novel therapies, devices, and consumer health products to market faster, addressing critical global health challenges. His strategic vision ensures that Johnson & Johnson Innovation continues to be a vital engine for external innovation, complementing the company's internal research and development efforts and ultimately benefiting patients worldwide.
Chris Picariello is the President of Johnson & Johnson Innovation. He leads the organization's strategic investments and partnerships to discover and advance groundbreaking healthcare solutions globally.
Chris Picariello, through Johnson & Johnson Innovation, invests in a wide range of healthcare sectors. His focus areas include pharmaceuticals, medical devices, and consumer health, with a particular interest in biotechnology, digital health, artificial intelligence, and other disruptive technologies that can improve patient care.
Chris Picariello works as the President of Johnson & Johnson Innovation, which is the strategic venturing and partnering arm of Johnson & Johnson. This organization operates globally with innovation centers in key biotech and healthcare hubs.
